| Financial Instruments Measured At Fair Value On A Recurring Basis |
Financial instruments measured at fair value on a recurring basis, by valuation hierarchy | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | Level 1 | | Level 2 | | Level 3 | | Total | | (in millions of U.S. dollars) | | | | | Assets: | | | | | | | | | Fixed maturities available-for-sale | | | | | | | | | U.S. and local government securities | $ | 1,442 | | | $ | 2,152 | | | $ | — | | | $ | 3,594 | | | Non-U.S. | — | | | 40,678 | | | 694 | | | 41,372 | | | Corporate and asset-backed securities | — | | | 44,385 | | | 3,542 | | | 47,927 | | | Mortgage-backed securities | — | | | 32,625 | | | — | | | 32,625 | | | | | | | | | | | 1,442 | | | 119,840 | | | 4,236 | | | 125,518 | | Equity securities (1) | 5,394 | | | — | | | 110 | | | 5,504 | | | Short-term investments | 3,074 | | | 2,374 | | | 10 | | | 5,458 | | Other investments (2) | 716 | | | 8,455 | | | — | | | 9,171 | | | Securities lending collateral | — | | | 1,870 | | | — | | | 1,870 | | | Investment derivatives | 34 | | | — | | | — | | | 34 | | | Derivatives designated as hedging instruments | — | | | 346 | | | — | | | 346 | | | Other derivative instruments | 15 | | | — | | | — | | | 15 | | | Separate account assets | 7,405 | | | 66 | | | — | | | 7,471 | | Total assets measured at fair value (1)(2)(3) | $ | 18,080 | | | $ | 132,951 | | | $ | 4,356 | | | $ | 155,387 | | | Liabilities: | | | | | | | | | Investment derivatives | $ | 371 | | | $ | — | | | $ | — | | | $ | 371 | | | Derivatives designated as hedging instruments | — | | | 127 | | | — | | | 127 | | | Other derivative instruments | 2 | | | — | | | — | | | 2 | | Market risk benefits (4) | — | | | — | | | 505 | | | 505 | | | Total liabilities measured at fair value | $ | 373 | | | $ | 127 | | | $ | 505 | | | $ | 1,005 | |
(1)Excluded from the table above are funds of $5,510 million, measured using NAV as a practical expedient. (2)Excluded from the table above are other investments of $1,851 million, principally investments measured using NAV as a practical expedient and policy loans. (3)Excluded from the table above are private equities of $17,385 million, measured using NAV as a practical expedient. (4)Refer to Note 10 for additional information on Market risk benefits. | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | Level 1 | | Level 2 | | Level 3 | | Total | | (in millions of U.S. dollars) | | | | | Assets: | | | | | | | | | Fixed maturities available-for-sale | | | | | | | | | U.S. and local government securities | $ | 1,481 | | | $ | 2,233 | | | $ | — | | | $ | 3,714 | | | Non-U.S. | — | | | 39,685 | | | 671 | | | 40,356 | | | Corporate and asset-backed securities | — | | | 44,340 | | | 3,546 | | | 47,886 | | | Mortgage-backed securities | — | | | 30,724 | | | — | | | 30,724 | | | | | | | | | | | 1,481 | | | 116,982 | | | 4,217 | | | 122,680 | | Equity securities (1) | 5,163 | | | — | | | 119 | | | 5,282 | | | Short-term investments | 2,657 | | | 2,138 | | | 45 | | | 4,840 | | Other investments (2) | 630 | | | 8,684 | | | — | | | 9,314 | | | Securities lending collateral | — | | | 2,500 | | | — | | | 2,500 | | | Investment derivatives | 22 | | | — | | | — | | | 22 | | | Derivatives designated as hedging instruments | — | | | 266 | | | — | | | 266 | | | Other derivative instruments | 11 | | | — | | | — | | | 11 | | | Separate account assets | 6,858 | | | 67 | | | — | | | 6,925 | | Total assets measured at fair value (1)(2)(3) | $ | 16,822 | | | $ | 130,637 | | | $ | 4,381 | | | $ | 151,840 | | | Liabilities: | | | | | | | | | Investment derivatives | $ | 242 | | | $ | — | | | $ | — | | | $ | 242 | | | Derivatives designated as hedging instruments | — | | | 232 | | | — | | | 232 | | | Other derivative instruments | — | | | 4 | | | — | | | 4 | | Market risk benefits (4) | — | | | — | | | 659 | | | 659 | | | Total liabilities measured at fair value | $ | 242 | | | $ | 236 | | | $ | 659 | | | $ | 1,137 | |
(1)Excluded from the table above are funds of $5,519 million, measured using NAV as a practical expedient. (2)Excluded from the table above are other investments of $1,435 million, principally investments measured using NAV as a practical expedient and policy loans. (3)Excluded from the table above are private equities of $17,239 million, measured using NAV as a practical expedient. (4)Refer to Note 10 for additional information on Market risk benefits.
|
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation |
The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3). Excluded from the tables below is the reconciliation of Market risk benefits, refer to Note 10 for additional information.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 (in millions of U.S. dollars) | | | Available-for-Sale Debt Securities | | | | Equity securities | | Short-term investments | | Non-U.S. | | Corporate and asset- backed securities | | | | | | | | | | | Balance, beginning of period | | | $ | 689 | | | $ | 3,536 | | | | | | | $ | 121 | | | $ | 11 | | | Transfers into Level 3 | | | — | | | 15 | | | | | | | — | | | — | | | Transfers out of Level 3 | | | (2) | | | (4) | | | | | | | (13) | | | — | | | Change in Net Unrealized Gains (Losses) in OCI | | | (2) | | | (11) | | | | | | | — | | | — | | | Net Realized Gains (Losses) | | | — | | | (11) | | | | | | | (1) | | | — | | | | | | | | | | | | | | | | | Purchases | | | 34 | | | 299 | | | | | | | 6 | | | 3 | | | Sales | | | (9) | | | (53) | | | | | | | (3) | | | — | | | Settlements | | | (16) | | | (229) | | | | | | | — | | | (4) | | | | | | | | | | | | | | | | | Balance, end of period | | | $ | 694 | | | $ | 3,542 | | | | | | | $ | 110 | | | $ | 10 | | | Net Realized Gains (Losses) Attributable to Changes in Fair Value at the Balance Sheet date | | | $ | (1) | | | $ | (15) | | | | | | | $ | (2) | | | $ | (6) | | | Change in Net Unrealized Gains (Losses) included in OCI at the Balance Sheet date | | | $ | (2) | | | $ | (14) | | | | | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 (in millions of U.S. dollars) | | | Available-for-Sale Debt Securities | | | | Equity securities | | Short-term investments | | Non-U.S. | | Corporate and asset- backed securities | | | | | | | | | | | Balance, beginning of period | | | $ | 587 | | | $ | 3,017 | | | | | | | $ | 113 | | | $ | 18 | | | Transfers into Level 3 | | | 10 | | | 60 | | | | | | | — | | | — | | | Transfers out of Level 3 | | | — | | | (12) | | | | | | | (1) | | | — | | | Change in Net Unrealized Gains (Losses) in OCI | | | 18 | | | (3) | | | | | | | — | | | — | | | Net Realized Gains (Losses) | | | 3 | | | (4) | | | | | | | 2 | | | — | | | | | | | | | | | | | | | | | Purchases | | | 84 | | | 295 | | | | | | | 19 | | | 25 | | | Sales | | | (34) | | | (53) | | | | | | | (8) | | | — | | | Settlements | | | (70) | | | (114) | | | | | | | — | | | (1) | | | | | | | | | | | | | | | | | Balance, end of period | | | $ | 598 | | | $ | 3,186 | | | | | | | $ | 125 | | | $ | 42 | | | Net Realized Gains (Losses) Attributable to Changes in Fair Value at the Balance Sheet date | | | $ | — | | | $ | (1) | | | | | | | $ | 4 | | | $ | — | | | Change in Net Unrealized Gains (Losses) included in OCI at the Balance Sheet date | | | $ | 16 | | | $ | (7) | | | | | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, 2026 (in millions of U.S. dollars) | | | Available-for-Sale Debt Securities | | | | Equity securities | | Short-term investments | | Non-U.S. | | Corporate and asset- backed securities | | | | | | | | | | | Balance, beginning of period | | | $ | 671 | | | $ | 3,546 | | | | | | | $ | 119 | | | $ | 45 | | | Transfers into Level 3 | | | 2 | | | 16 | | | | | | | — | | | — | | | Transfers out of Level 3 | | | (2) | | | (21) | | | | | | | (13) | | | — | | | Change in Net Unrealized Gains (Losses) in OCI | | | (12) | | | (25) | | | | | | | — | | | (2) | | | Net Realized Gains (Losses) | | | — | | | (18) | | | | | | | (1) | | | — | | | | | | | | | | | | | | | | | Purchases | | | 110 | | | 410 | | | | | | | 12 | | | 11 | | | Sales | | | (39) | | | (54) | | | | | | | (7) | | | — | | | Settlements | | | (36) | | | (312) | | | | | | | — | | | (44) | | | | | | | | | | | | | | | | | Balance, end of period | | | $ | 694 | | | $ | 3,542 | | | | | | | $ | 110 | | | $ | 10 | | | Net Realized Gains (Losses) Attributable to Changes in Fair Value at the Balance Sheet date | | | $ | (1) | | | $ | (18) | | | | | | | $ | (2) | | | $ | (6) | | | Change in Net Unrealized Gains (Losses) included in OCI at the Balance Sheet date | | | $ | (12) | | | $ | (32) | | | | | | | $ | — | | | $ | (1) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, 2025 (in millions of U.S. dollars)
| | | Available-for-Sale Debt Securities | | | | Equity securities | | Short-term investments | | Non-U.S. | | Corporate and asset- backed securities | | Mortgage-backed securities | | | | | | | | | Balance, beginning of period | | | $ | 604 | | | $ | 2,891 | | | $ | 3 | | | | | $ | 120 | | | $ | 14 | | | Transfers into Level 3 | | | 11 | | | 84 | | | — | | | | | — | | | — | | | Transfers out of Level 3 | | | — | | | (13) | | | — | | | | | (1) | | | — | | | Change in Net Unrealized Gains (Losses) in OCI | | | 38 | | | (7) | | | — | | | | | — | | | — | | | Net Realized Gains (Losses) | | | (3) | | | (6) | | | $ | (2) | | | | | (3) | | | — | | | | | | | | | | | | | | | | | Purchases | | | 144 | | | 514 | | | 1 | | | | | 26 | | | 30 | | | Sales | | | (87) | | | (100) | | | (2) | | | | | (17) | | | — | | | Settlements | | | (109) | | | (177) | | | — | | | | | — | | | (2) | | | | | | | | | | | | | | | | | Balance, end of period | | | $ | 598 | | | $ | 3,186 | | | $ | — | | | | | $ | 125 | | | $ | 42 | | | Net Realized Gains (Losses) Attributable to Changes in Fair Value at the Balance Sheet date | | | $ | (1) | | | $ | (4) | | | $ | — | | | | | $ | 9 | | | $ | — | | | Change in Net Unrealized Gains (Losses) included in OCI at the Balance Sheet date | | | $ | 30 | | | $ | (17) | | | $ | — | | | | | $ | — | | | $ | — | |
|
| Carrying Values And Fair Values Of Financial Instruments Not Measured At Fair Value |
The following tables present fair value, by valuation hierarchy, and carrying value of the financial instruments not measured at fair value:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | Fair Value | | Net Carrying Value | | (in millions of U.S. dollars) | Level 1 | | Level 2 | | Level 3 | | Total | | | Assets: | | | | | | | | | | | Private debt held-for-investment | $ | — | | | $ | — | | | $ | 2,289 | | | $ | 2,289 | | | $ | 2,252 | | | Total assets | $ | — | | | $ | — | | | $ | 2,289 | | | $ | 2,289 | | | $ | 2,252 | | | Liabilities: | | | | | | | | | | | Repurchase agreements | $ | — | | | $ | 3,368 | | | $ | — | | | $ | 3,368 | | | $ | 3,368 | | | Short-term debt | — | | | 652 | | | — | | | 652 | | | 663 | | | Long-term debt | — | | | 15,694 | | | 590 | | | 16,284 | | | 17,452 | | | Hybrid debt | — | | | 482 | | | — | | | 482 | | | 427 | | | Total liabilities | $ | — | | | $ | 20,196 | | | $ | 590 | | | $ | 20,786 | | | $ | 21,910 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | Fair Value | | Net Carrying Value | | (in millions of U.S. dollars) | Level 1 | | Level 2 | | Level 3 | | Total | | | Assets: | | | | | | | | | | | Private debt held-for-investment | $ | — | | | $ | — | | | $ | 2,445 | | | $ | 2,445 | | | $ | 2,411 | | | Total assets | $ | — | | | $ | — | | | $ | 2,445 | | | $ | 2,445 | | | $ | 2,411 | | | Liabilities: | | | | | | | | | | | Repurchase agreements | $ | — | | | $ | 3,324 | | | $ | — | | | $ | 3,324 | | | $ | 3,324 | | | Short-term debt | — | | | 1,498 | | | — | | | 1,498 | | | 1,499 | | | Long-term debt | — | | | 14,045 | | | 576 | | | 14,621 | | | 15,728 | | | Hybrid debt | — | | | 484 | | | — | | | 484 | | | 422 | | | Total liabilities | $ | — | | | $ | 19,351 | | | $ | 576 | | | $ | 19,927 | | | $ | 20,973 | |
|